Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Change in Acquisitions & Divestments (2021 - 2023)

Historic Change in Acquisitions & Divestments for SOPHiA GENETICS (SOPH) over the last 3 years, with Q2 2023 value amounting to $1.3 million.

  • SOPHiA GENETICS's Change in Acquisitions & Divestments fell 9355.76% to $1.3 million in Q2 2023 from the same period last year, while for Dec 2023 it was $17.5 million, marking a year-over-year decrease of 7765.78%. This contributed to the annual value of $17.5 million for FY2023, which is 7765.78% down from last year.
  • According to the latest figures from Q2 2023, SOPHiA GENETICS's Change in Acquisitions & Divestments is $1.3 million, which was down 9355.76% from $16.2 million recorded in Q1 2023.
  • SOPHiA GENETICS's Change in Acquisitions & Divestments' 5-year high stood at $21.6 million during Q1 2022, with a 5-year trough of $1.3 million in Q2 2023.
  • Over the past 3 years, SOPHiA GENETICS's median Change in Acquisitions & Divestments value was $16.2 million (recorded in 2023), while the average stood at $15.3 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first skyrocketed by 3774.52% in 2022, then tumbled by 9355.76% in 2023.
  • Quarter analysis of 3 years shows SOPHiA GENETICS's Change in Acquisitions & Divestments stood at $10.9 million in 2021, then surged by 37.75% to $15.0 million in 2022, then tumbled by 91.13% to $1.3 million in 2023.
  • Its last three reported values are $1.3 million in Q2 2023, $16.2 million for Q1 2023, and $15.0 million during Q4 2022.